Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia

Iman Shaheen1, Noha Ibrahim

  • 1Department of Clinical and Chemical Pathology, Cairo University, Cairo, Egypt. iman.shym@yahoo.com

Insights

Receptor tyrosine kinase-1 (ROR1) is overexpressed in pediatric acute lymphoblastic leukemia (ALL). This finding suggests ROR1 may be a valuable target for developing new immunotherapies for ALL.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Receptor tyrosine kinases (RTKs) are key targets in cancer therapy.
  • Human orphan receptor tyrosine kinase-1 (ROR1) is an RTK implicated in various cancers.
  • ROR1 overexpression is observed in B-cell chronic lymphocytic leukemia.

Purpose of the Study:

  • To investigate the expression profile of ROR1 in pediatric acute lymphoblastic leukemia (ALL).
  • To assess the potential of ROR1 as a therapeutic target in pediatric ALL.

Main Methods:

  • Quantitative analysis of ROR1 expression.
  • Comparison of ROR1 levels between pediatric ALL patients and a control group.
  • Utilized ROR1/β-actin ratio for expression quantification.

Main Results:

  • ROR1 was significantly overexpressed in pediatric ALL patients compared to the control group (P = 0.024).
  • The ROR1/β-actin ratio was elevated in children with ALL.

Conclusions:

  • ROR1 is overexpressed in pediatric ALL, indicating its potential as a tumor-associated antigen.
  • ROR1 represents a promising target for developing novel immunotherapies for pediatric ALL.